-+ 0.00%
-+ 0.00%
-+ 0.00%

Pathos AI closed a $237 million Series E round to expand the smart AI drug development platform and advance the oncology pipeline.

智通财经·10/23/2026 13:09:28
语音播报
Pathos AI closed a $237 million Series E round to expand the smart AI drug development platform and advance the oncology pipeline.